Home > Boards > US Listed > Medical - Drugs >

Seelos Therapeutics Inc (SEEL)

SEEL RSS Feed
Add SEEL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/24/2021 9:12:40 AM - Followers: 247 - Board type: Free - Posts Today: 0

Seelos Therapeutics, Inc.:
https://seelostherapeutics.com/

Seelos Therapeutics, Inc.
300 Park Avenue
New York, NY 10022


SEC Filings: https://seelostherapeutics.com/sec-filings/


Press Releases:
 https://seelostherapeutics.com/press-releases-2/

FOCUS:
Addressing unmet needs in neurological diseases and disorders and in rare diseases
Advancing multiple late-stage therapeutic candidates for CNS disorders
Developing therapeutics with proven mechanisms of action
Identifying opportunities in large markets

Seelos Therapeutics is exploring new ways to think about and treat central nervous system (CNS) disorders in neurological diseases and disorders and in rare diseases. Our trials are designed to further evaluate the safety and efficacy of our acquired assets. These come to Seelos with well characterized efficacy and safety, thereby avoiding much of the lengthy and burdensome process of preclinical R&D.

By working with clinically ready novel and reformulated compounds we will move from asset acquisition to meaningful data readouts in an expedited and efficient fashion. It is our goal to develop unique and disruptive therapies and approaches to improve treatment of large known diseases, offer new treatments for large unmet or recently characterized indications as well as advance therapies for orphan indications.

Our approach to this process will require development that is appropriate and efficient for a company our size in the scope of work each program requires in regards to trial size and duration.

We invite you to stay update on the progress of our assets in our clinical development programs.



Our Seelos Therapeutics Pipeline (as of May 2020)


SEEL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SEEL News: Current Report Filing (8-k) 05/12/2022 04:32:30 AM
SEEL News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 05/12/2022 04:31:12 AM
SEEL News: Quarterly Report (10-q) 05/10/2022 12:24:27 PM
SEEL News: Additional Proxy Soliciting Materials (definitive) (defa14a) 05/05/2022 04:00:57 AM
SEEL News: Analysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Masimo (MASI) 05/04/2022 03:35:21 AM
PostSubject
#30292   SEEL https://seelostherapeutics.com/investors-and-media/ harr449 11/24/21 09:12:40 AM
#30291   https://ih.advfn.com/stock-market/NASDAQ/seelos-therapeutics-SEEL/stock-news/866 G2G 11/24/21 09:00:36 AM
#30290   Undervalued trickledownfacists 11/11/21 11:28:12 AM
#30289   Pipeline updated October 2021: harr449 11/08/21 04:53:57 PM
#30288   Seelos Therapeutics Announces FDA Acceptance of Investigational New harr449 11/08/21 09:46:38 AM
#30287   6,561,278 shares traded today. mik1234 10/22/21 10:49:25 PM
#30286   Yup trickledownfacists 10/07/21 01:00:43 PM
#30285   Sharp dip in first 30 minutes, down 6%. 2.20. harr449 10/06/21 10:50:33 AM
#30284   Oct. 05, 2021 Seelos Therapeutics Should Be harr449 10/05/21 05:29:28 PM
#30283   Can’t wait for great news so flippers harr449 09/29/21 05:48:33 PM
#30282   Added. trickledownfacists 09/29/21 01:24:12 PM
#30281   WTH, abrupt .20 drop. 11:18 AM. harr449 09/29/21 11:51:00 AM
#30280   Upgrade ahead of this.....hmmmm. Somebody wants to look LINK Oracle 09/27/21 02:05:30 PM
#30279   Monster trickledownfacists 09/27/21 11:13:57 AM
#30278   ty for post. Bought 1000 shares. harr449 09/27/21 09:38:17 AM
#30277   Wow harr449 09/27/21 09:33:06 AM
#30276   Boom trickledownfacists 09/27/21 09:27:32 AM
#30275   Big Price Target Increase! Invest83838 09/27/21 08:45:22 AM
#30274   $SEEL Roth Capital analyst Jonathan Aschoff upgrades Seelos G2G 09/27/21 08:41:18 AM
#30272   That's probably correct harr449 Invest83838 09/22/21 06:37:26 AM
#30271   imo, people loaded up last week on news leak. harr449 09/21/21 04:11:14 PM
#30270   I Haven't Sold Smart Money Invest83838 09/21/21 03:41:40 PM
#30269   Yup, AEZS next. trickledownfacists 09/21/21 02:14:53 PM
#30268   $1.90-2.50's= $$$$ G2G 09/21/21 02:10:36 PM
#30267   Ahahahahahahahahahahaha trickledownfacists 09/21/21 01:43:02 PM
#30266   Still running trickledownfacists 09/21/21 01:37:17 PM
#30265   DONT SEEL https://www.massgeneral.org/news/press-release/Investigational-drug-re G2G 09/21/21 01:29:26 PM
#30264   SEEL Gets FDA clearance for SLS-005 in ALS, G2G 09/21/21 01:10:28 PM
#30263   Ya! trickledownfacists 09/21/21 01:03:47 PM
#30262   Pop back over $2s trickledownfacists 09/21/21 12:53:37 PM
#30261   Big blocks….. trickledownfacists 09/15/21 11:06:05 AM
#30260   Running trickledownfacists 09/15/21 10:49:07 AM
#30259   Back over $2 trickledownfacists 09/15/21 10:07:42 AM
#30258   Like it trickledownfacists 09/14/21 02:29:30 PM
#30257   SEEL been going down since stock offering was issued. harr449 09/14/21 02:06:54 PM
#30256   Peep trickledownfacists 09/14/21 03:26:36 AM
#30255   SEEL is the opposite of your MEME Invest83838 09/13/21 07:39:35 PM
#30254   it had a nice set up but looks Nebuchadnezzar 09/13/21 07:35:20 PM
#30253   Nebuchadneezzar so you think there is hope for SEEL? Invest83838 09/13/21 07:32:02 PM
#30252   2 conferences this month. trickledownfacists 09/09/21 03:23:49 PM
#30251   $$$ SEEL $$$ on watch Nebuchadnezzar 09/04/21 02:28:10 AM
#30250   $2 is the new floor. trickledownfacists 09/03/21 11:17:38 AM
#30249   Hopefully, a reversal now. harr449 08/25/21 03:07:24 PM
#30248   Cheap trickledownfacists 08/25/21 12:46:03 PM
#30247   ty, didn’t see. harr449 08/19/21 07:51:47 PM
#30246   Someone sold a 400k block into the open market trickledownfacists 08/19/21 06:36:38 PM
#30245   WTH happened today? Low $1.60. harr449 08/19/21 06:26:22 PM
#30244   Seelos Therapeutics Announces Mid-Year 2021 Business and Clinical Update harr449 08/10/21 11:08:01 AM
#30243   Wish we could track daily change in OS. harr449 07/26/21 09:25:02 AM
#30242   Could easily be back to $4-5 by year Argus63 07/26/21 07:03:55 AM
PostSubject
Consent Preferences